drugset / Trial / NCT05623891
Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors
NaSingle-groupOpen-labelDiagnostic
Summary
This is a single arm study to evaluate the safety and biodistribution of 177Lu-labeled anti-ED-B mAbs SPECT imaging in patients with ED-B positive solid tumors.
Timeline
- Start
- 2022-12
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-B5-IgG4 | Monoclonal antibody | 5 mg | Intravenous |
| Subject | 177Lu-B5-IgG4 | Monoclonal antibody | 10 unknown | Intravenous |